(0.27%) 5 145.50 points
(0.29%) 38 553 points
(0.36%) 17 911 points
(-0.81%) $83.17
(1.35%) $1.949
(-0.14%) $2 343.80
(0.15%) $27.58
(0.85%) $929.90
(-0.30%) $0.932
(-0.40%) $10.98
(-0.40%) $0.797
(0.25%) $92.11
0.00% HKD 0.265
Live Chart Being Loaded With Signals
Tianda Pharmaceuticals Limited, an investment holding company, engages in the research and development, production, and sale of pharmaceutical, biotechnology, and healthcare products in Mainland China, Hong Kong, and Australia...
Stats | |
---|---|
Объем за сегодня | 10 000.00 |
Средний объем | 395 016 |
Рыночная капитализация | 569.76M |
EPS | HKD0 ( 2023-08-28 ) |
Last Dividend | HKD0.00260 ( 2023-06-29 ) |
Next Dividend | HKD0 ( N/A ) |
P/E | -26.50 |
ATR14 | HKD0 (0.00%) |
Tianda Pharmaceuticals Корреляция
10 Самые положительные корреляции |
---|
10 Самые отрицательные корреляции |
---|
Вы знали?
Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).
Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.
Tianda Pharmaceuticals Финансовые показатели
Annual | 2023 |
Выручка: | HKD532.09M |
Валовая прибыль: | HKD255.53M (48.02 %) |
EPS: | HKD-0.0112 |
FY | 2023 |
Выручка: | HKD532.09M |
Валовая прибыль: | HKD255.53M (48.02 %) |
EPS: | HKD-0.0112 |
FY | 2022 |
Выручка: | HKD546.69M |
Валовая прибыль: | HKD251.52M (46.01 %) |
EPS: | HKD-0.0254 |
FY | 2022 |
Выручка: | HKD509.96M |
Валовая прибыль: | HKD241.22M (47.30 %) |
EPS: | HKD-0.0101 |
Financial Reports:
No articles found.
Tianda Pharmaceuticals Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
HKD0.0112 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0.00260 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | HKD0.00450 | 2010-07-23 |
Last Dividend | HKD0.00260 | 2023-06-29 |
Next Dividend | HKD0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 14 | -- |
Total Paid Out | HKD0.0530 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 1.23 | -- |
Div. Sustainability Score | 4.25 | |
Div.Growth Potential Score | 0 | |
Div. Directional Score | 1.955 | -- |
Year | Amount | Yield |
---|
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
6033.HK | Ex Dividend Knight | 2023-09-19 | Semi-Annually | 0 | 0.00% | |
1818.HK | Ex Dividend Junior | 2023-06-07 | Annually | 0 | 0.00% | |
0848.HK | Ex Dividend Junior | 2023-05-24 | Annually | 0 | 0.00% | |
0006.HK | Ex Dividend Knight | 2023-08-30 | Semi-Annually | 0 | 0.00% | |
2588.HK | Ex Dividend Knight | 2023-09-25 | Semi-Annually | 0 | 0.00% | |
1382.HK | Ex Dividend Knight | 2023-08-15 | Semi-Annually | 0 | 0.00% | |
0455.HK | Ex Dividend Junior | 2023-06-29 | Annually | 0 | 0.00% | |
6823.HK | Ex Dividend Knight | 2023-08-17 | Semi-Annually | 0 | 0.00% | |
1931.HK | Ex Dividend Knight | 2023-09-04 | Semi-Annually | 0 | 0.00% | |
0966.HK | Ex Dividend Junior | 2023-07-10 | Sporadic | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -0.0454 | 1.500 | -0.908 | -1.362 | [0 - 0.5] |
returnOnAssetsTTM | -0.0263 | 1.200 | -0.878 | -1.053 | [0 - 0.3] |
returnOnEquityTTM | -0.0405 | 1.500 | -1.561 | -2.34 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 1.099 | 0.800 | 9.51 | 7.61 | [1 - 3] |
quickRatioTTM | 0.854 | 0.800 | 9.68 | 7.75 | [0.8 - 2.5] |
cashRatioTTM | 0.518 | 1.500 | 8.23 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.120 | -1.500 | 7.99 | -10.00 | [0 - 0.6] |
interestCoverageTTM | -5.45 | 1.000 | -3.13 | -3.13 | [3 - 30] |
operatingCashFlowPerShareTTM | -0.0241 | 2.00 | -0.00802 | -0.0160 | [0 - 30] |
freeCashFlowPerShareTTM | -0.0424 | 2.00 | -0.0212 | -0.0424 | [0 - 20] |
debtEquityRatioTTM | 0.187 | -1.500 | 9.25 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.480 | 1.000 | 5.33 | 5.33 | [0.2 - 0.8] |
operatingProfitMarginTTM | -0.0545 | 1.000 | -3.09 | -3.09 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | -0.468 | 1.000 | -3.71 | -3.71 | [0.2 - 2] |
assetTurnoverTTM | 0.580 | 0.800 | 9.47 | 7.57 | [0.5 - 2] |
Total Score | 4.25 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -23.59 | 1.000 | -2.48 | 0 | [1 - 100] |
returnOnEquityTTM | -0.0405 | 2.50 | -1.003 | -2.34 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -0.0424 | 2.00 | -0.0141 | -0.0424 | [0 - 30] |
dividendYielPercentageTTM | 0.981 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | -0.0241 | 2.00 | -0.00802 | -0.0160 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.156 | 1.500 | -2.30 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | -0.0972 | 1.000 | -4.93 | 0 | [0.1 - 0.5] |
Total Score | -0.341 |
Tianda Pharmaceuticals
Tianda Pharmaceuticals Limited, an investment holding company, engages in the research and development, production, and sale of pharmaceutical, biotechnology, and healthcare products in Mainland China, Hong Kong, and Australia. Its product range includes Chinese medicines, chemical drugs, biological and health products, and medical appliances covering the area of cardio-cerebrovascular, pediatric, anti-flu and respiratory, anti-infection, detoxification, urological agents, and others. The company offers its health products under the Herb Valley and Tuokang brands. It also engages in the sale and wholesale of Chinese herbal medicines, traditional Chinese medicine decoction pieces and Chinese medicines; provision of Chinese medical services; and trading of agricultural by-products. The company was formerly known as Tianda Holdings Limited and changed its name to Tianda Pharmaceuticals Limited in September 2012. The company was incorporated in 1992 and is headquartered in Central, Hong Kong. Tianda Pharmaceuticals Limited is a subsidiary of Tianda Group Limited.
О Торговые сигналы
Данные торговые сигналы, представленные на этой странице, помогают определить, когда следует ПОКУПАТЬ или ПРОДАВАТЬ NA. Сигналы имеют задержку более 1 минуты. Пожалуйста, примите во внимание, что существует вероятность ошибки или неточностей в силу различных микро и макро факторов влияющих на фондовые рынки.
Данные тор“о”ые сигна“ы не являются определен“ыми, и getagraph.com не несет ответственности за какие-либо действия, предпринятые в от“ошении этих сигналов, как описано в Terms of Use. Сигналы основаны на широком спектре индикаторов технического анализа